Patents by Inventor Steven Gallinger

Steven Gallinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assessment of risk for colorectal cancer
    Patent number: 8153369
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: April 10, 2012
    Assignees: Cancer Care Ontario, McGill University
    Inventors: Michelle Cotterchio, Steven Gallinger, Celia Greenwood, Thomas J. Hudson, Brent W. Zanke, Michael Phillips, Saravanan Sundararajan, Alexandre Montpetit, Phillippe Laflamme, Vincent Ferretti
  • ASSESSMENT OF RISK FOR COLORECTAL CANCER
    Publication number: 20110189663
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).
    Type: Application
    Filed: March 5, 2008
    Publication date: August 4, 2011
    Applicants: CANCER CARE ONTARIO, MCGILL UNIVERSITY
    Inventors: Michelle Cotterchio, Steven Gallinger, Celia Greenwood, Thomas J. Hudson, Brent W. Zanke, Michael Phillips, Saravanan Sundararajan, Alexandre Montpetit, Phillippe Laflamme, Vincent Ferretti
  • ASSESSMENT OF RISK FOR COLORECTAL CANCER
    Publication number: 20100047782
    Abstract: Disclosed is a method for identifying an individual who has an altered risk for developing colorectal cancer comprising detecting a single nucleotide polymorphism (SNP).
    Type: Application
    Filed: June 5, 2007
    Publication date: February 25, 2010
    Applicants: CANCER CARE ONTARIO, MCGILL UNIVERSITY
    Inventors: Michelle Cotterchio, Steven Gallinger, Celia Greenwood, Thomas J. Hudson, Brent W. Zanke, Michael Phillips, Saravanan Sundararajan, Alexandre Montpetit, Phillippe Laflamme, Vincent Ferretti
  • Animal model of the human immune system
    Patent number: 5663481
    Abstract: The present invention relates to a non-human chimeric mammal having characteristics of a functional human immune system and having functional human lymphocytes reconstituted in the mammal's lymphopoietic tissue, particularly the spleen. The invention also relates to a method of preparing a non-human chimeric mammal, having characteristics of a functional human immune system, by engraftment of human peripheral blood leukocytes into an immunocompromised mammal. Use of the chimeric mammal as a model of the human immune system is described.
    Type: Grant
    Filed: August 6, 1993
    Date of Patent: September 2, 1997
    Assignee: Mount Sinai Hospital Corporation
    Inventors: Steven Gallinger, Nobumichi Hozumi, John C. Roder, Jasbir S. Sandhu, Baruch Shpitz